Cargando…
Protein Expression Profile of HT-29 Human Colon Cancer Cells after Treatment with a Cytotoxic Daunorubicin-GnRH-III Derivative Bioconjugate
Targeted delivery of chemotherapeutic agents is a new approach for the treatment of cancer, which provides increased selectivity and decreased systemic toxicity. We have recently developed a promising drug delivery system, in which the anticancer drug daunorubicin (Dau) was attached via oxime bond t...
Autores principales: | Schreier, Verena Natalie, Pethő, Lilla, Orbán, Erika, Marquardt, Andreas, Petre, Brindusa Alina, Mező, Gábor, Manea, Marilena |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3981732/ https://www.ncbi.nlm.nih.gov/pubmed/24718594 http://dx.doi.org/10.1371/journal.pone.0094041 |
Ejemplares similares
-
Enhanced In Vitro Antitumor Activity of GnRH-III-Daunorubicin Bioconjugates Influenced by Sequence Modification
por: Schuster, Sabine, et al.
Publicado: (2018) -
Improved in vivo antitumor effect of a daunorubicin - GnRH-III bioconjugate modified by apoptosis inducing agent butyric acid on colorectal carcinoma bearing mice
por: Kapuvári, Bence, et al.
Publicado: (2016) -
Drug targeting to decrease cardiotoxicity – determination of the cytotoxic effect of GnRH-based conjugates containing doxorubicin, daunorubicin and methotrexate on human cardiomyocytes and endothelial cells
por: Polgár, Livia, et al.
Publicado: (2018) -
Suitability of GnRH Receptors for Targeted Photodynamic Therapy in Head and Neck Cancers
por: Pethő, Lilla, et al.
Publicado: (2019) -
Novel Crizotinib–GnRH Conjugates Revealed the Significance of Lysosomal Trapping in GnRH-Based Drug Delivery Systems
por: Murányi, József, et al.
Publicado: (2019)